Developing new drugs for Parkinson's disease
Official title: ALBANY MOLECULAR RESEARCH INC:1106422 [20-006949]
Funded at Albany Molecular Research, INC. · NIH-10285556 · Data updated 2026-11-12
This study is working on developing new medications to help people with Parkinson's disease by creating and testing small compounds that could improve symptoms or slow down the disease.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Albany Molecular Research, INC. NIH-funded |
| Lab location | 1 site (Albany, United States) |
| Project start | September 25, 2020 |
| Project end | September 24, 2025 |
| Funding year | 2020 |
| Award (this year) | $160,419 |
| NIH project number | 271201500005I-0-759502000001-1 |
| Project ID | NIH-10285556 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with Parkinson's disease who are seeking new treatment options.
✕Less likely to help
Patients who do not have Parkinson's disease or related neurological disorders may not benefit from this research.
What this research studies
This research focuses on creating new therapeutic compounds aimed at treating Parkinson's disease. It involves a comprehensive approach that includes designing and synthesizing small molecules, testing their absorption and metabolism, and evaluating their effectiveness as inhibitors of specific enzymes related to the disease. Patients may benefit from the development of novel drugs that could improve their symptoms or slow disease progression. The research utilizes advanced techniques in medicinal chemistry and biological assays to identify promising drug candidates.
Why it matters
Potential benefit: If successful, this research could lead to the development of new medications that effectively treat Parkinson's disease.
How similar studies have gone: Previous research in medicinal chemistry has successfully led to the development of new treatments for neurological disorders, indicating a promising potential for this approach.
Where this research is happening
-
Albany Molecular Research, INC.
Albany, United States Active
Researchers
- Principal investigator: Allard, Melissa — Albany Molecular Research, INC.
- Study coordinator: Allard, Melissa
Related research
Other NIH-funded projects on the same topics.
-
Accelerating the development of new drugs for neurological conditions
This study is all about finding and creating new medicines for brain-related conditions faster, so that patients can have more treatment options that are safe and effective.
-
Developing new drugs to manage pain and substance use disorders
This study is working on new medications to help people manage pain better and tackle issues with substance use, aiming to create treatments that could improve your quality of life.
-
Improving treatments for antibiotic-resistant bacterial infections
This study is working on creating new treatments for tough infections caused by antibiotic-resistant bacteria, like Acinetobacter and Pseudomonas aeruginosa, to help patients who currently have limited options for effective care.
-
Developing a new treatment for safety evaluation and clinical trials.
This study is working on a new medicine called NCGC00413972 to make sure it’s safe and effective for people, with the hope that it could offer new treatment options in the future.
-
Investigating ways to improve pain management and drug formulation.
This study is all about finding better ways to manage pain by creating new and improved medications, and it’s designed for patients who are looking for effective pain relief options.
-
Developing new treatments for Alzheimer's Disease through medicinal chemistry
This study is exploring new ways to create medications for Alzheimer's Disease that could help patients by targeting the specific processes involved in the condition.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.